Evidence map›Paper›PMID 34843594›Full record

ArticlePloS one2021

Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria.

Mohammed Mustapha, Basira Kankia Lawal, Abubakar Sha'aban, Abubakar Ibrahim Jatau, Abubakar Sadiq Wada, Auwal Adam Bala, Sagir Mustapha, Anas Haruna, Abbas Musa, Mubarak Hussaini Ahmad and 5 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mohammed MustaphaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Pulau Pinang, Malaysia.ORCID 0000-0002-5021-1610
Basira Kankia LawalFaculty of Pharmaceutical Sciences, Department of Clinical Pharmacy and Pharmacy Management, Kaduna State University, Kaduna, Nigeria.ORCID 0000-0003-1975-0648
Abubakar Sha'abanSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Pulau Pinang, Malaysia.
Abubakar Ibrahim JatauSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia.
Abubakar Sadiq WadaDepartment of Pharmacology and Therapeutics, Bayero University Kano, Kano, Nigeria.
Auwal Adam BalaDepartment of Pharmacology, College of Medicine and Health Sciences, Federal University Dutse, Jigawa, Nigeria.ORCID 0000-0003-0402-9639
Sagir MustaphaDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Anas HarunaFaculty of Pharmaceutical Sciences, Department of Pharmaceutical and Medicinal Chemistry, Kaduna State University, Kaduna, Nigeria.
Abbas MusaFaculty of Pharmaceutical Sciences, Department of Clinical Pharmacy and Pharmacy Management, Kaduna State University, Kaduna, Nigeria.
Mubarak Hussaini AhmadFaculty of Pharmaceutical Sciences, Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Kaduna, Nigeria.
Salim IliyasuDepartment of Pharmaceutics and PharmaceuticalTechnology, Bayero University Kano, Kano, Nigeria.
Surajuddeen MuhammadFaculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Kaduna, Nigeria.
Fatima Zaji MohammedSchool of Dental Health Sciences, Shehu Idris Institute of Health Sciences and Technology, Kaduna State University, Makarfi, Kaduna, Nigeria.
Ahmed Danbala AhmedFaculty of Pharmaceutical Sciences, Department of Pharmacology and Toxicology, Kaduna State University, Kaduna, Nigeria.
Hadzliana ZainalSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Pulau Pinang, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Students of the health sciences are the future frontliners to fight pandemics. The students' participation in COVID-19 response varies across countries and are mostly for educational purposes. Understanding the determinants of COVID-19 vaccine acceptability is necessary for a successful vaccination program. This study aimed to investigate the factors associated with COVID-19 vaccine acceptance among health sciences students in Northwest Nigeria. The study was an online self-administered cross-sectional study involving a survey among students of health sciences in some selected universities in Northwest Nigeria. The survey collected pertinent data from the students, including socio-demographic characteristics, risk perception for COVID-19, and willingness to accept the COVID-19 vaccine. Multiple logistic regression was used to determine the predictors of COVID-19 vaccine acceptance. A total of 440 responses with a median (interquartile range) age of 23 (4.0) years were included in the study. The prevalence of COVID-19 vaccine acceptance was 40.0%. Factors that independently predict acceptance of the vaccine were age of 25 years and above (adjusted odds ratio, aOR, 2.72; 95% confidence interval, CI, 1.44-5.16; p = 0.002), instructions from heads of institutions (aOR, 11.71; 95% CI, 5.91-23.20; p<0.001), trust in the government (aOR, 20.52; 95% CI, 8.18-51.51; p<0.001) and willingness to pay for the vaccine (aOR, 7.92; 95% CI, 2.63-23.85; p<0.001). The prevalence of COVID-19 vaccine acceptance among students of health sciences was low. Older age, mandate by heads of the institution, trust in the government and readiness to pay for the vaccine were associated with acceptance of the vaccine. Therefore, stakeholders should prioritize strategies that would maximize the vaccination uptake.

Indexed as

Patient Acceptance of Health CareStudentsUniversitiesAdultCOVID-19 VaccinesFemaleHumansLogistic ModelsMaleMultivariate AnalysisNigeriaRisk FactorsYoung AdultCOVID-19 Vaccines

Identifiers

PMID34843594
PMCPMC8629299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.